Epidemiological studies suggest that HSV-2 increases the risk of HIV-1 acquisition. 1, 2, 3 In populations with HSV-2 prevalence of 80%, nearly 50% of HIV-1 infections are attributable to an HSV-2 ...

WOBURN, Mass. and OXFORD, England, July 8, 2022 /PRNewswire/ -- Rational Vaccines, a company focused on revolutionizing the treatment and prevention of herpes to eradicate the disease, today announced ...

BNT163 is the first candidate from BioNTech’s infectious disease mRNA vaccine collaboration with the University of Pennsylvania to enter the clinic The program is part of BioNTech’s strategy to ...

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

System from Quest Diagnostics’ products business is first FDA-cleared Herpes Simplex Virus 1 and 2 test that uses genital swab or cerebrospinal fluid (CSF) specimen collection Quest Diagnostics (NYSE: ...

Genital herpes is one of the most common types of sexually transmitted infections (STI) in the United States – as well as one of the most frustrating. Characterized by periodic blisters on the ...

As per the data released by the World Health Organisation (WHO), 3.7 billion people globally have herpes simplex virus type 1 (HSV 1) and 491 million have herpes simplex virus type 2 (HSV-2) infection ...

This is a preview. Log in through your library . Abstract Objective: The objective of this study was to estimate the prevalence and correlates of herpes simplex virus type 2 infection in women in an ...

The Herpevac Trial evaluated a herpes simplex virus type 2 (HSV-2) glycoprotein D (gD2) subunit vaccine to prevent genital herpes. Unexpectedly, the vaccine protected against genital HSV-1 infection ...

Serum YKL-40 levels in patients with cervical cancer are elevated compared to patients with cervical intraepithelial neoplasia and healthy controls No significant financial relationships to disclose.

Patients aged ≥ 18 years with HSV culture-positive persistent (i.e. non-healing) herpetic lesions or who were experiencing culture-positive HSV recurrences (≥ 1 every other month) from seven centres ...